The emergence of catalysis in a noncatalytic protein scaffold is a rare, unexplored event. Chalcone isomerase (CHI), a key enzyme in plant flavonoid biosynthesis, is presumed to have evolved from a nonenzymatic ancestor related to the widely distributed fatty-acid binding proteins (FAPs) and a plant protein family with no isomerase activity (CHILs). Ancestral inference supported the evolution of CHI from a protein lacking isomerase activity. Further, we identified four alternative founder mutations, i.e., mutations that individually instated activity, including a mutation that is not phylogenetically traceable. Despite strong epistasis in other cases of protein evolution, CHI's laboratory reconstructed mutational trajectory shows weak epistasis. Thus, enantioselective CHI activity could readily emerge despite a catalytically inactive starting point. Accordingly, X-ray crystallography, NMR, and molecular dynamics simulations reveal reshaping of the active site toward a productive substratebinding mode and repositioning of the catalytic arginine that was inherited from the ancestral fatty-acid binding proteins. 
nzymes generally diverge from other enzymes by exploiting preexisting promiscuous activities while maintaining key catalytic residues. Moreover, enzymes often evolve into regulatory or scaffolding proteins through loss of catalytic residues 1 . However, the opposite evolutionary trend seems exceedingly rare: emergence of enzyme catalysis starting from a noncatalytic, ancestral protein [2] [3] [4] [5] . Chalcone isomerase (CHI) is enigmatic in this regard. CHI is a key enzyme in the biosynthesis of plant flavonoids-specialized metabolites involved in diverse biotic and abiotic functions including UV protection, flower color, pollen development, root nodulation, plant architecture and chemical defenses 6 . CHI catalyzes the enantioselective formation of the tricyclic flavanone (S)-naringenin from its bicyclic precursor chalconaringenin (Fig. 1a) . However, the only two homologous protein families identified to date are nonenzymatic 7 : the phylogenetically dispersed and presumably more ancient fatty-acid binding proteins (FAP) and a family of closely related plant proteins dubbed CHI-like (CHIL). FAPs play a role in fatty-acid biosynthesis 7 and are found in plants, as well as in some algae, protists and bacteria. In contrast, CHI and CHILs have been identified only in plants. CHILs exhibit no CHI activity. Their expression correlates with flavonoid biosynthesis 8, 9 , but their biochemical activity remains unknown. Given that neither FAPs nor CHILs show CHI activity, and that FAPs are likely the oldest of the three families, the parsimonious hypothesis is that CHI evolved from a nonenzymatic protein 7 . However, given the evolutionary distance between FAPs and CHIs, and the rarity of cases in which enzymes evolved from noncatalytic proteins, CHI's ancestor may have been an isomerase, and activity was subsequently lost in CHILs. Phylogeny alone cannot reveal when CHI catalysis emerged or the trajectory that led from a nonenzymatic ancestor to a bona fide CHI. Using a combination of ancestral sequence inference, directed evolution, X-ray crystallography, NMR, and MD simulations, we have ascertained that CHI evolved from a protein devoid of chalcone isomerase activity. Due to uncharacteristically weak epistasis, enantioselective isomerase activity could easily emerge, primarily via repositioning of both the substrate and of a catalytic arginine residue that was already present in the nonenzymatic ancestor.
Results
Ancestral sequence inference. We inferred three ancestral nodes by maximum likelihood 10 : the most probable ancestor of all chalcone isomerases (ancCHI), of all CHI-like proteins (ancCHIL), and the CHI/CHIL common ancestor (ancCC). Given the wide divergence between CHIs and FAPs, an earlier ancestor was not inferred. Details of the procedure and prediction statistics are provided in the Supplementary Information and in Methods. Briefly, because protein sequence divergence between CHI, CHIL, and FAPs is high, and includes insertions and deletions (InDels), we generated a structure-based alignment (Supplementary Table 1 , Supplementary  Fig. 1 , and Supplementary Dataset 1) . No systematic InDels were found between the CHI and CHIL lineages. Hence, the structural alignment was trimmed in loop regions and at the N and C termini and a phylogenetic tree was generated ( Fig. 1b ; see Supplementary  Fig. 2 for the complete tree). Remaining gaps and ambiguously aligned positions were handled manually in the reconstructed ancestors (Supplementary Dataset 2 and Supplementary Fig. 3 ).
Five residues were previously identified as being important for catalysis in extant CHIs 7, 11 and, as expected, these were all present in the most probable ancCHI sequence (posterior probabilities P = 0.84-0.98). Of these, R34, T46, and Y104 (ancCC sequence numbering is used throughout), which are highly conserved in extant CHIs (80-100%; Supplementary Fig. 1 and Supplementary Dataset 1), are present in ancCC (P = 0.97-0.98). For the remaining An adaptive trajectory from inactive ancestor to CHI. Can a putative, historically relevant mutational trajectory be reconstructed that connects ancCC and ancCHI? We addressed this question using a phylogenetic library approach, i.e., by examining various combinations of the amino acid exchanges that separate the inferred ancCC and ancCHI sequences. Though these two sequences differ by 65 amino acids (out of 220), we posit that most of these nonconserved exchanges have no substantial contribution to the acquisition of enzymatic activity. Therefore, to limit library size, we constructed a variant of ancCHI, dubbed ancCHI*, in which exchanges in positions that are nonconserved and/or distant from the active site were excluded. AncCHI* differed from ancCC at 39 Table 3 ). The first library was generated by randomly incorporating 39 oligonucleotides into the ancCC gene, each encoding one amino acid exchange, at an average rate of two exchanges per gene (Supplementary Tables 4 and 5 ). Expression in E. coli and activity-based screening of > 700 clones in clarified cell lysates identified several variants with isomerization rates above background (Fig. 2a) . Several mutations were enriched, particularly L108V (15 out of 23 clones, Supplementary Note 1). A variant containing only L108V was also identified (~2.5-fold increased isomerization rate compared to the uncatalyzed background reaction). The L108V variant, hereafter called ancR1, was purified and its catalytic activity verified (Fig. 2a,b and Supplementary Table 3 ). The activity of this variant and other early mutants was too low to accurately determine k cat and K M values, but assays with purified proteins consistently indicated rate enhancements above background, in agreement with the lysate measurements (Supplementary Tables 3 and 7) .
Six additional rounds of library construction (alternating between spiking of ancestral mutations and shuffling of improved variants) and screening were performed, yielding variant ancR7 that exhibited only three-fold lower catalytic efficiency compared to ancCHI* (k cat /K M = 7.6 × 10 4 M −1 s
; Supplementary Tables 3, 5  and 6 and Supplementary Note 1). All variants showed the same enantioselectivity as extant CHIs (Fig. 2b and Supplementary  Table 3 ), suggesting that CHI's enantioselectivity was embedded in the inactive ancCC scaffold. The emerging evolutionary trajec- Posterior probabilities and the inferred ancestral nodes are annotated. All genes group according to the major plant clades with the exception of CHIL from Treubia lacunosa, a liverwort, which is located within the lycophyte clade (indicated by the asterisk). The complete phylogenetic tree is shown in Supplementary Fig. 2 , and the alignment used to generate it is given in Supplementary Fig. 1 and Supplementary Dataset 1.
tory represents a viable adaptive pathway with gradual increases in activity and diminishing returns in later rounds (Fig. 2c) 
15
. Interestingly, ancR7 contained only four of the five previously identified catalytic amino acids (S111N fixed, but not V188T), indicating that the V188T exchange plays a relatively minor role in CHI's catalytic emergence.
The availability of several nonepistatic founder mutations. Our initial screen identified L108V as the likeliest founder mutation, i.e., a single mutation that can initiate CHI activity on its own. To identify alternative founder mutations, we screened a second R1 library with a low mutation rate (0.2 amino acid exchanges/gene) such that all possible single mutants were likely represented (> 900 clones, ~5 × oversampling; Supplementary Table 5) . Two additional founder mutations were identified ( Fig. 2a) : M36I, resulting in a 1.3-fold higher catalytic rate compared to the background reaction, and I99L, with a 2.0-fold increase. To explore possible second mutations, we screened three low-mutation-rate R2 libraries, each based on one of the three founder mutations (Supplementary Table 5 ). The improved variants each contained the remaining two founder mutations (Supplementary Note 2), suggesting a high degree of additivity. Whether mutations have additive effects or not is a crucial evolutionary constraint. Non-additivity, or epistasis, means that the effect of a mutation is dependent on other mutations. Epistasis dictates a specific order by which mutations accumulate along a given trajectory, thus reducing the number of accessible pathways. It can change the magnitude of effects (e.g., a mutation shifting from being slightly to highly beneficial at the background of another mutation) and even the sign (e.g., a shift from deleterious to beneficial). Previous studies have highlighted the prevalence of epistasis and, in particular, sign epistasis [15] [16] [17] [18] [19] [20] [21] [22] [23] . However, when examining the effects of combinations of founder mutations, we observed only mild magnitude epistasis-all three founder mutations led to some activity increase regardless of which mutation was present first (Fig. 3a) . The triple mutant (ancCC + M36I + I99L + L108V) led to the highest activity, further supporting the theory that the effect of these three founder mutations is largely additive, thus indicating a smooth, 'uphill' trajectory (Fig. 3a) . The absence of strong epistasis is further evidenced by the fact that reversion of any of the three founder mutations in ancCHI* resulted in only minor reductions in k cat /K M (4-6-fold; Supplementary Table 7) .
In addition to various combinations of founder mutations, the L108V library contained improved variants with either K100T or S111N as the second mutation, the latter being one of the two remaining active site exchanges discussed above. A combinatorial mutational analysis confirmed that neither of these second mutations can serve as a founder mutation, as on their own they do not elicit activity in ancCC (Fig. 3b ). This analysis also explained why neither K100T nor S111N were found in any selected variant: in the background of either M36I or I99L, K100T was nearly neutral, whereas S111N reduced activity. The fact that the effects of K100T and S111N develop only in the presence of L108V reinforces the key role of this mutation in initiating CHI's catalytic emergence.
By the fourth round, all three founder mutations-M36I, I99L, and L108V-and both second-stage mutations-K100T and S111N-were fixed, and together accounted for most of the activity gains. The quintuple mutant is only four-fold less active in lysate and five-fold in terms of k cat /K M compared to ancR4, which contains six additional mutations.
An alternative pathway not seen in CHI's phylogeny. The above experiment sampled mutations that are phylogenetically traceable, i.e., sequence exchanges between the inferred ancestral nodes ancCC and ancCHI. However, alternative routes may exist that were either not explored by natural evolution or were historically explored but are no longer visible in the phylogenetic record. We thus subjected ancCC to random mutagenesis. We performed four rounds of random mutagenesis by alternating between error-prone PCR (1.5 amino acid substitutions/gene on average) and DNA shuffling and screening for CHI activity ( Fig. 4a ; Supplementary Table 5; Supplementary Note 3). Approximately 1,100 clones were sampled in round 1. Strikingly, none of the abovementioned phylogenetic founder mutations was observed. Most of the active variants identified were mutated at position F133, predominantly to Leu (7/19 sequenced clones), as well as to Ile or Ser (two clones each). Thus, F133L seems like an alternative to the phylogenetic trajectory, as long as this trajectory can be inferred from the extant sequences. Though there is a reasonable probability that Leu was present in ancCC (P(L) = 0.12 compared to P(F) = 0.84), it is negligibly predicted in ancCHI (p(F) = 0.90, P(L) < 0.01; Supplementary Table 8 ). Accordingly, position 133 is predominantly Phe in extant CHIs (85%), whereas Leu is rare (3.4%), and Ile and Ser are not found (Supplementary Table 8 ). By round ep4, higher activity evolved, and four additional mutations were fixed ( Fig. 4a and Supplementary Table 9 ), three of which resemble F133L in terms of not being widely represented in extant CHIs and not exhibiting significant prediction probabilities in ancCHI (Supplementary Table 8 ). Nonetheless, as observed in the ancestral trajectory, all variants exclusively produced (S)-naringenin (Supplementary Table 3 ), reinforcing our hypothesis that enantioselectivity was embedded in ancCC's precatalytic site.
At first glance, it may seem like the error-prone trajectory, which reached a k cat /K M of only 1.6 × 10 3 M −1 s −1 (Fig. 4a and  Supplementary Table 3) , lags behind the ancestral trajectory (Fig. 2c) . However, the two trajectories are not directly comparable. First, the ancestral libraries primarily contained beneficial or neutral mutations, whereas the vast majority of random mutations are deleterious 24 . Second, ancR4 contains 11 mutations compared to only 5 in epR4. However, the key question is whether the two trajectories are bridgeable, or incompatible, as commonly observed in evolutionary trajectories (i.e., combining their mutations leads to loss of activity) 23, 25, 26 . To this end, we introduced the random founder mutation F133L into various ancestral intermediates ( Fig. 4b and Supplementary Table 7) . F133L is slightly deleterious in the background of the most catalytically active ancestral founder mutation (L108V) yet beneficial in the two others (M36I and I99L). When added to the more advanced intermediates (R3, R7 and even ancCHI*), F133L exerts no substantial effect. It therefore seems that the occurrence of F133L along the phylogenetic trajectory would fail to yield an adaptive advantage. F133L could theoretically be fixed as a nearly neutral mutation and be purged later on. Indeed, the fact that F133L is deleterious in an extant CHI indicates that incompatibility only occurred at the later stages of evolution and explains why Leu at position 133 is inferred with negligible probability in ancCHI.
Overall, the above results reinforce the conclusion of facile emergence of CHI despite its origin from a catalytically inactive ancestor: multiple founder mutations and subsequent trajectories are available with unexpectedly weak functional epistasis. In other words, the evolutionary landscape underlying CHI's emergence is smooth rather than rugged.
The structural and mechanistic basis of CHI's emergence. CHI's catalytic activity has been attributed to five residues 7, 11, 27 . R34 aligns the substrate and stabilizes the transition state by interacting with the attacking 2′ -hydroxyl (Figs. 1a and 5a). The other four residues form hydrogen bonds with the carbonyl oxygen (T46 and Y104) and 6′ -OH (N111 and T188; ancCC numbering), thus directing substrate binding and favoring ring closure to give the S-enantiomer (Fig. 5a ). R34, T46, and Y104 seem most critical to CHI's activity, and these three residues are already present in ancCC (Fig. 5b) . The catalytic arginine dates back to FAPs, in which it is absolutely conserved and coordinates the negatively charged carboxylate of the bound fatty acids 7 . Why then is the inferred ancestor catalytically inactive, and how do the identified mutations enable the emergence of catalysis and enantioselectivity?
We solved the X-ray crystal structures of various evolutionary intermediates (Supplementary Table 10 and Supplementary Fig. 7 ). The observed changes are subtle and relate to the repositioning of specific active site side chains rather than to global rearrangements (Supplementary Table 11 and Supplementary Figs. 8-10 ). Along the trajectory, mutations occurred from the inside out, i.e., starting with first-shell mutations and then appearing progressively outward from the active site to second and third shells ( Supplementary  Fig. 11 ). This trend suggests that the late mutations fine tune the structural effects of the early mutations 15 . Most noticeably, substitution of L108 by the shorter Val side chain in ancR1 enlarges the active site cavity, thus favoring productive substrate binding modes (Fig. 5c ). When crystals of ancCC (1.5 Å resolution) and ancR1 (1.4 Å) were soaked with racemic (R/S)-naringenin ( Fig. 5b and Supplementary Figs. 7 and 12 ), we observed a ligand orientation that is the opposite of the one observed in Medicago sativa CHI (MsCHI, PDB ID 1EYQ; Fig. 5a ) 27 and likely is nonproductive. Because complexes could not be obtained for the other variants, we performed MD simulations to further explore the two contrasting binding modes (dubbed "ancCC-like" and "CHI-like"). Specifically, we docked in chalconaringenin in either the productive or nonproductive orientation into the crystal structures of various evolutionary intermediates and followed their positional changes over time ( Fig. 5d and Supplementary  Figs. 13 and 14) . Note that productive and nonproductive modes include structures in which the substrate is not ideally aligned with either of the two modes, with some r.m.s. deviation fluctuations still observed but retaining the proper orientation and being fully bound in the active site. When the substrate was placed in the CHI-like mode, it remained in this orientation in all structures, supporting the theory that this mode is indeed the productive one (Fig. 5d) . However, when the substrate was initially placed in the nonproductive ancCC-like mode, a complex trend was observed. In both ancCC and ancR1, the substrate tends to either dissociate or remain in the active site while adopting a variety of alternative nonproductive orientations ( Fig. 5d and Supplementary Fig. 15 ). In ancR3, a more advanced evolutionary intermediate, productive binding was first observed, and in ancR7 nonproductive ancCC-like binding was eliminated (Fig. 5d) . Control simulations of the ancCC and ancR1 crystal structures in complex with (S)-naringenin showed that the product complexes were stable over the course of the simulation, indicating that the observed instabilities of the ancCC-like substrate binding mode are not a simulation artifact (Supplementary Fig. 16 ). Thus, one important factor in the emergence of CHI activity is a change in substrate positioning.
Concomitantly, changes in the conformational ensemble of the catalytic arginine occurred. R34 assumes various rotamers in the structures of different evolutionary intermediates, and in extant CHIs (overall, the position of the guanidinium carbon varies by up to 7.7 Å; Fig. 6a and Supplementary Figs. 9 and 10) . Nonetheless, it appears that a consistent change in the most populated rotamers accompanied the emergence of isomerase activity, as indicated by both NMR and MD simulations. The NMR chemical shift of the guanidinium N ε is well resolved. Three other arginines that reside on the protein surface were mutated to lysines (R113K, R115K, and R134K) in key evolutionary intermediates (ancCC-, ancR1-, ancR3-and ancR7-Δ R; see Online Methods). This resulted in an unambiguous resonance signature for the catalytic arginine side chain in the Figs. 17 and 18 ). Aggregation of ancR3-Δ R excluded it from our NMR analyses, but changes in the steady-state heteronuclear NOE effect were readily measured in the other variants, providing dynamics of pico-to-nanosecond thermal fluctuations of 15 N-1 H bond vectors 28 . The NOE intensity for R34 is low relative to the average backbone values in ancCC-, ancR1-and ancR7-Δ R, suggesting that the guanidinium moiety of R34 displays faster motion than the proteins' overall tumbling (Fig. 6b) . The decrease in the relative NOE intensity of R34 between ancCC-Δ R and ancR1-Δ R is consistent with an increase in R34 side chain mobility in ancR1-Δ R. This increased flexibility may be attributable to increased available space in the active site due to the L108V substitution (Fig. 5c) . The relative NOE intensity increases again in ancR7-Δ R, suggesting Selected active site residues are labeled. b, Crystal structure of ancCC with NAR bound in the ancCC-like mode. Three key residues are already present (yellow circles). S111 exists in two conformers, which are both shown. c, The structural alignment of ancCC and ancR1 with MsCHI with NAR bound (Ca alignment with PyMOL, r.m.s. deviation = 1.14 Å; van der Waals radii of CD2 and C7 are shown) reveals a likely steric clash between (S)-naringenin and the side chain of L108 in ancCC (distance CD2 to C7 ~2 Å), suggesting that the CHI-like binding mode is incompatible with ancCC. AncR1 harbors an activating substitution, L108V, which alleviates the steric clash by reducing the length of the side chain by a methylene moiety, increasing active site volume. d, Percentage of simulation time in which the substrate assumes a particular binding mode in ancCC, ancR1, ancR3, and ancR7 after initially being placed in either the productive (top panel) or nonproductive mode (bottom panel). Each variant was simulated in five replicas (100 ns each). The last 50 ns of each simulation was combined, and r.m.s. deviation-based clustering using the average linkage algorithm was applied to calculate the fraction of time in which the substrate resides in the productive, nonproductive, or other binding modes (illustrated in Supplementary Fig. 11 ) dissociates from the active site. Additional simulations performed with ancCHI and AtCHI are shown in Supplementary Figs. 9 and 10. that R34 becomes less flexible in this advanced evolutionary intermediate. First and foremost, a large change in chemical shift was observed, indicating a change in R34's average chemical environment (Fig. 6c) . The modulation in mobility and average location of R34 was recapitulated in MD simulations that included ancR3 (Fig. 6d) . A substantial narrowing in the ensemble of accessible arginine rotamers was observed along the evolutionary trajectory, with ancR1's ensemble being most dispersed (Fig. 6d) . The increased mobility of R34 in ancR1 compared to both the starting point, ancCC, and the advanced intermediates, ancR3 and ancR7, was also reflected in the root-mean square fluctuation (RMSF) of its side chain (Supplementary Fig. 19 ). We conclude that the emergence of CHI catalysis occurred via reshaping of the active site cavity to allow the substrate to bind in a productive mode, thereby also repositioning R34 and enabling it to exert its catalytic effect.
Discussion
Our results indicate that CHI evolved from a catalytically inactive ancestor, thus demonstrating that emergence of catalysis and stereospecificity in noncatalytic scaffolds is a feasible evolutionary scenario. That said, a bacterial CHI 29 has evolved independently in an enzymatic protein fold, exemplifying that plant CHI is an exception rather than the rule. The actual, historical ancestor may have exhibited some isomerase activity, but this activity is unlikely to have exceeded a low, promiscuous level. The three founder mutations that initiate CHI activity were individually inferred in ancCC with tangible posterior probabilities (P(I36) = 0.11, P(L99) = 0.14, and P(V108) = 0.04). However, the likelihood that ancCC contained all three mutations, and was hence a fully active enzyme, is negligible.
The fact that the inferred ancestor is devoid of CHI activity is also interesting because other inferred enzyme ancestors have been found to be multifunctional, typically harboring varying levels of the activities found in the extant protein families that diverged from them 30 . Here we have obtained an ancestor that is not multifunctional, at least with respect to the isomerase activity. However, the function of this ancestor remains unknown, first and foremost because the function of contemporary CHILs is also unknown. Presumably, the function of ancCC or extant CHILs relates to binding of phenylpropanoids, as suggested by binding of (S)-naringenin to ancCC in a mode that differs from CHI's.
Unraveling the ancestral function is a challenge also because at the time when ancCC and the early CHI precursors emerged, flavonoid biosynthesis must have been in its infancy 31 . This ancestral context is obviously lost in modern plants. Nonetheless, in the context of an ancient, rudimentary metabolism, emergence from a nonenzymatic protein and via intermediates that are relatively inefficient enzymes as shown here seems plausible. Given the high spontaneous rate of chalcone cyclization (half-life for isomerization ~3.6 h), a weak catalyst or even a binding protein that directs enantioselectivity could prove beneficial to the fitness of the organismal host 32, 33 . CHI's evolution seems unique not only in having its origins in an inactive ancestor, but also in following a smooth, largely additive trajectory. In fact, we surmise that these two features, and the relatively facile spontaneous rate of chalcone cyclization, are related; namely, it is the absence of strong epistasis and the preexisting uncatalyzed cyclization rate that made ancCC a feasible evolutionary starting point despite its lack of initial activity. Multiple parallel trajectories to CHI activity exist-four different founder mutations were identified and various additive combinations thereof (Figs. 3  and 4 ). This trend contrasts with previous studies supporting the prevalence of epistasis in protein evolution, including sign epistasis, and especially that between founder mutations [15] [16] [17] [18] [19] [20] [21] [22] [23] . Beyond enzymatic function, the mutations that initiated CHI's function affected stability: the apparent melting temperatures of the evolutionary intermediates were reduced by up to 13 °C compared to ancCC (Supplementary Table 2 ). Given the high stability of ancCC 34 , this destabilization had no phenotypic effects, but the actual, historical intermediates may have been affected. Nevertheless, in terms of function, the mutations along CHI's emergence show uncharacteristically additive effects. This may relate to the preexistence of three key catalytic residues; however, key catalytic residues also preexisted in enzyme trajectories that showed strong epistasis 15, 23, 35, 36 . Low energetic and steric demands of the reaction may be another factor, but these are also not unique to this trajectory 15, 23 . A more likely explanation in our view is that the combined likelihood of emergence from a completely inactive starting point and via a rugged, epistatic trajectory is exceedingly low. In other words, for an enzymatically inactive protein to be a viable starting point, founder mutations must arise with relatively high likelihood.
Finally, the fact that CHI's ancestor is inactive despite all key catalytic residues being in place is analogous to the current limitations of de novo enzyme design. Catalytic residues can be placed within a suitable cavity, yet not taking dynamics into account results in geometries that only roughly match catalytically productive conformations and yields poor enzymes, at best, that generally need to be improved by directed evolution [37] [38] [39] . The presence of catalytic residues is necessary, but not sufficient. However, once an initial activity level arises, mutations in other residues, often distal from the active site, enable large improvements in catalytic efficiency 40, 41 . As seen in the evolution of CHI, subtle changes in substrate positioning and in the position and flexibility of the catalytic residues relative to the bound substrate can trigger activity in a formerly inactive pocket.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41589-018-0042-3.
Ancestral reconstruction. To generate a phylogenetic tree, we mined the 1KP transcriptome database 42 for CHI and CHIL sequences. We also included sequences of several biochemically characterized CHI proteins as well as sequences from NCBI protein BLAST. We covered all major plant lineages (liverworts, mosses, lycophytes, ferns, gymnosperms, and angiosperms) except for hornworts, where no CHI or CHIL sequences could be identified among the three transcriptomes (and zero genomes) available at the time. Though mosses contain CHILs, no CHI sequences were found in this lineage. Due to the large number of available transcriptomes, redundant sequences (≥ 70%) were removed. However, because the early taxa (liverworts, mosses) were underrepresented in the databases, we included several such sequences despite higher identity. Overall, 88 CHI and 43 CHIL sequences were included (Supplementary Table 1 ). Six previously reported FAPb sequences that are the most closely related to CHI and CHIL 7 were included as outgroup. A structure-based alignment ( Supplementary Fig. 1 and Supplementary Dataset 1) was created with Expresso 43 using the crystal structures of AtCHI (PDB ID 4DOI, TAIR gene accession number AT3G55120), CHIL (4DOK, AT5G05270), and FAPb (4DOL, AT1G53520). Poorly aligned regions (loops, N-and C termini) were trimmed. Positions that could not be trimmed unambiguously were initially kept. A phylogenetic tree was generated with MrBayes 44 and showed a consensus from a 1 million generation run (Fig. 1b and Supplementary Fig. 2 ). The tree was largely consistent with the tree of life. Note that moss CHILs take up the outgroup position within the CHIL clade. However, the relationship between basal land plants is still under debate 45 . AncCHI, ancCHIL, and ancCC were predicted using FastML and the JTT substitution matrix 46 . Alternative substitution models were tested and gave nearly identical results. By default, we chose the amino acids with the highest posterior probabilities to derive the most probable ancestral sequences. Remaining gaps and ambiguously aligned positions were handled manually as described in detail in Supplementary Fig. 3 and Supplementary Dataset 2. The N-and C-terminal amino acids were predicted with large ambiguity, and hence identical adaptor sequences derived from AtCHI were added to each ancestor (Supplementary Fig. 1 and Supplementary Dataset 2) . Ultimately, we obtained three 220-amino acid proteins, with pairwise sequence identities of 89% for ancCC/ancCHIL, 70% for ancCC/ancCHI, and 60% for ancCHI/ancCHIL.
Protein expression and purification. Synthetic genes for the three ancestors were ordered from Hylabs. All variants were cloned into pHis8 (a modified pET28 vector containing an N-terminal His8-tag) using NcoI and HindIII. Plasmids were transformed into E. coli BL21 (DE3). Cells were grown at 37 °C in LB containing 50 μ g/mL Kanamycin to an optical density at 600 nm (OD600) of 0.6-1. Overnight expression was induced by addition of 1 M IPTG and the temperature reduced to 18 °C. Cells were harvested by centrifugation, resuspended and lysed by sonication in Column Washing buffer (50 mM Tris-HCl, pH 8.0, 500 mM NaCl, 20 mM imidazole, 10% glycerol) supplemented with 1% Tween 20, 10 mM β -mercaptoethanol, 100 μ g/mL lysozyme, benzonase (Novagen) at a dilution of 10 4 -10
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, and protease inhibitor cocktail for purification of His-tagged proteins (Sigma). Cell debris was removed by centrifugation, and the clarified lysate was passed through a 45 μ M filter before purification with Nickel beads (Adar Biotech). The Elution buffer differed from the Column Washing buffer in that it contained 250 mM imidazole. Proteins were dialyzed overnight against Activity buffer (50 mM HEPES pH 7.5, 150 mM NaCl) and concentrated over spin-column concentrators if necessary. Protein concentration was determined using the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific).
Synthesis of chalconaringenin.
Chalconaringenin was synthesized as previously described 47 with minor modifications. Naringenin (2 g, Sigma-Aldrich) was treated with 5% NaOH in methanol (50 mL) under reflux for 2 h. Subsequently, 200 mL of 1 M HCl were added to the mixture, and the aqueous layer was extracted three times with ethyl acetate. The combined organic layers were washed with brine and water, dried over Na 2 SO 4 , and evaporated. The crude product was further purified by silica gel column chromatography using a hexane:ethylacetate gradient (100% hexane, then 7:1, 3:1, 2:1). Enzyme assays. Naringenin formation was followed by the decrease in absorbance at 390 nm (chalconaringenin is yellow; naringenin is colorless), typically in a Synergy HT spectrophotometer (Bio-TEK). To determine the activity in crude cell lysates, cells were grown at a 500 μ L culture volume in 96-well plates and lysed as described below under 'Screening' . Lysates were diluted (from no dilution up to a 10,000-fold dilution for extant CHIs) to determine initial rates of chalconaringenin isomerization (in the range of μ M/min). One volume of 200 μ M chalconaringenin in 50 mM HEPES, pH 7.5 and 5% ethanol was added to one volume of diluted cell lysate. Initial rates were normalized to cell density (OD 600 ), corrected for the dilution factor, and averaged. For the data shown in Figs. 2-4 and Supplementary  Tables 3 and 7 , each variant was grown in at least two wells and the average determined. The whole experiment (cell growth, protein expression, lysis and enzymatic assay) was repeated three times and the combined average determined. For directed evolution, each well contained a different variant (except for the respective control, i.e. the best variant from the previous round, which was grown in at least triplicate on each plate). Improved variants were regrown and assayed in triplicate.
Specific activity was determined with purified proteins (micromole product generated per minute per milligram of protein) at a substrate concentration of 100 μ M and the average and s.d. of three technical repeats determined. For determination of kinetic parameters, assays were performed at 12 different substrate concentrations (4.5-180 μ M) in 50 mM HEPES pH 7.5 with 5% ethanol as co-solvent. The spontaneous, background rates in buffer were subtracted, and the net initial rates were directly fit to the Michaelis-Menten model using Kaleidagraph. In cases where no substantial rate saturation was observed, k cat /K M was extracted by a linear fit. The rate constant of the spontaneous reaction was calculated from a linear fit of initial rates in buffer (k uncat = 1.05 × 10 Supplementary Fig. 5 ). The spontaneous isomerization rate of chalconaringenin is relatively high. Hence, for the early evolutionary intermediates, assays were performed at enzyme concentration that exceeded substrate concentration ([E] 0 > [S] 0 ). These could reveal k cat values that are lower than k uncat . For those proteins reported as inactive (for example, ancCC) no activity above the background rate was detected at up to 50 μ M protein.
Determination of enantioselectivity.
Proteins were incubated with 60 μ M chalconaringenin in 50 mM HEPES, pH 7.5 for 30 min at room temperature (20-25° C). For low-activity mutants, up to 1 mM of protein ( > 10-fold excess over substrate) was used. Naringenin was extracted with 0.5 volumes of ethyl acetate. The organic phase was concentrated in a SpeedVac and centrifuged to remove residual precipitated protein, and the sample was analyzed on a chiral HPLC column (Lux 5 u Cellulose-4, 150 × 4.6 mm, Phenomenex) using a linear gradient (88% hexane/12% ethanol, 0.1% TFA) and a flow rate of 1.5 ml/min. Chalconaringenin (retention time 5.6 min), (R)-naringenin (8.1 min) and (S)-naringenin (6.7 min) were detected by absorbance at 310 nm, in which substrate and products absorb to a similar extent. The traces of (R)-naringenin detected in case of the low-activity variants are likely due to the spontaneous background reaction that generates racemic product.
Thermostability assays. Solutions of 10 μ M protein were heated with 10 × SYPRO Orange (Sigma) in 50 mM HEPES pH 7.5 to a final temperature of 25 up to 95 °C, at a ramp of 0.9 °C/min, in a Viia 7 Real-Time PCR system (Applied Biosystems). The increase in fluorescence that likely results from protein unfolding was monitored (excitation 488 nm, emission 500-750 nm). The apparent melting temperature (T m ) is the midpoint of the resulting temperature-fluorescence transition curve and was determined from the minimum value of the first derivative. Measurements were performed in triplicate and average T m values determined. The stability of selected variants was also measured by following changes in tryptophan fluorescence upon heat-induced unfolding in a Prometheus NT.48 NanoDSF instrument (NanoTemper Technologies). Solutions of 10 μ M protein were heated in 50 mM HEPES pH 7.5 from 20 to 95 °C at a ramp of 2 °C/min, the observed fluorescence ratios at (excitation 280 nm; emission 330 nm/350 nm) were plotted against temperature, and T m values determined as the minimum of the first derivative.
Cloning and library construction. Phylogenetic libraries.
To reduce library size, we sought to remove neutral mutations. To this end, an evolutionary conservation analysis was performed with ConSurf 48 , Supplementary Fig. 6a ). Considering also the location of each substitution in the protein structure (using the crystal structure of Medicago sativa CHI with bound product, PDB ID 1EYQ), we identified and reverted 29 nonconserved and/or peripheral substitutions in ancCHI to ancCC's amino acids, thus yielding ancCHI* (Supplementary Fig. 6b ). The catalytic activity of ancCHI* was confirmed as being similar to ancCHI (~2-fold lower k cat /K M , Supplementary Table 3 ). The libraries were created with ISOR (Incorporating Synthetic Oligonucleotides via Gene Reassembly 49 ) at an average mutation rate of two amino acid exchanges/gene. For the round 1 library, ancCC was shuffled with 39 oligonucleotides, each containing one mutation to ancCHI's amino acid (Supplementary Table 4 ). In cases where the amino acid exchange could only have occurred by two base substitutions, the oligonucleotide was partially randomized to include the plausible intermediary amino acid(s). Because several of the ancestral exchanges were at nearby positions, the primer set was updated after each round to avoid the reversion of ancCHI mutations that were fixed in the previous rounds (see Supplementary Table 4 for an example). Overall, seven rounds of library construction and screening were performed. Low-mutation-rate libraries were generated in the same manner, but at a mutation rate of 0.2 amino acid exchanges/gene. To ensure that all single mutations were represented with substantial probability, ~930 variants were screened for each of the four low-rate libraries (~5 × oversampling). More details on library generation and screening are given in Supplementary Table 5 .
Random mutagenesis libraries. Random libraries were created by alternating rounds of error-prone PCR and DNA shuffling. Error-prone PCR was performed using the GeneMorph II Random Mutagenesis kit (Agilent) according to the manufacturer's instructions. The average mutation rate was determined by sequencing a sample of randomly selected variants, and libraries with an average of 1.2 amino acid substitutions/gene (~2 nucleotide substitutions/gene) were screened. DNA shuffling was performed with StEP (Staggered Extension Process) 50 . More details on library generation and screening are given in Supplementary Table 5 .
Site-directed mutagenesis. Mutants were constructed as described in the QuikChange Site-Directed Mutagenesis manual (Agilent).
Library screening. Libraries were clones into pHis8, transformed into E. coli BL21 (DE3) and plated on kanamycin LB-agar plates. Single colonies were picked into deep 96-well plates and grown overnight at 30 °C in 200 μ L LB per well supplemented with 50 μ g/mL kanamycin. Wells containing fresh LB/kanamycin (500 μ L) were inoculated with 25 μ L of this preculture, and protein expression was induced as above. Cells were pelleted by centrifugation and the supernatant removed. Cell lysis was achieved by freezing for 30 min at − 80 °C, resuspending in 200μ L of Activity buffer supplemented with 0.1% Triton-X100, 100 μ g/mL lysozyme, and 0.25-2.5 U/mL benzonase (Novagen) and incubating for 30 min at room temperature. Cell debris was pelleted by centrifugation and 20-100 μ L of clarified lysate (or dilutions thereof, depending on the activity level of the library) were removed to assay for CHI activity. Substrate buffer (Activity buffer supplemented with 1% DMSO and chalconaringenin) was added to a final volume of 200 μ L at a final substrate concentration of 50-180 μ M, and the initial rates of naringenin formation were determined. Improved variants (compared to the best variant of the previous round) were picked and regrown in triplicate, and the initial rates re-measured and the average values determined. Plasmid DNA was isolated, and variants were sequenced ( Supplementary Notes 1-3) . The plasmids were retransformed, and the resulting single colonies were used to inoculate new cultures for activity determination and protein purification.
X-ray crystallography. Proteins purified by Ni-NTA affinity chromatography were prepared for crystallization by elution from a Superdex 200 size-exclusion column in buffer containing 25 mM Tris (pH 8.0), 200 mM NaCl and 2 mM DTT. Proteins were crystallized by hanging-drop vapor-diffusion at 4 °C. Protein crystals of ancCC and ancR1 were grown overnight at a concentration of 150 mg/mL in 42% MPD and 50 mM acetic acid (pH 4.5). Protein crystals of ancR2 were grown overnight at a concentration of 100 mg/mL in 25% PEG 4 K, 2.5 M ammonium formate and 100 mM succinic acid (pH 5.5). Protein crystals of ancR3 formed overnight at a concentration of 200 mg/ml in 25% PEG 4 K, 2.5 M ammonium formate and 100 mM succinic acid, pH 5.5. Protein crystals of ancR5 were grown over 2 weeks at a concentration of 140 mg/mL in 3.5 mM ammonium sulfate and 100 mM TAPS (pH 8.5). Protein crystals of ancR7 grew over the course of 1 month at a concentration of 50 mg/mL in 500 mM NaCl, 100 mM NaCitrate tribasic dihydrate (pH 5.6), and 2% ethylene imine polymer. Protein crystals of ancCHI* grew over 1 week at a concentration of 100 mg/ml in 4.5 M NaCl and acetic acid, pH 4.5. Protein crystals of epR4 grew in 2 d at a concentration of 120 mg/ml in 29% PEG 4 K, 2.5 M ammonium formate and 50 mM succinic acid, pH 5.5. After growth, protein crystals of ancCC and ancR1 were transferred to a condition with 65% MPD, 50 mM acetic acid (pH 4.5) and 20 mM naringenin and soaked for 3 d. Increasing the concentration of MPD increased the solubility of naringenin in this crystallography buffer and further improved the diffraction quality of the ancCC and ancR1 crystals from approximately 2.7 Å (before dehydration) to approximately 1.4Å and 1.5Å (after dehydration), respectively. The higher resolution data enabled a detailed comparison of conformational differences between ancCC and ancR1, particularly for the evaluation of R34. Other protein crystals produced in this study were not successfully soaked with either naringenin or chalcone substrates. Crystals of ancR2 were bathed briefly in a cryoprotectant solution containing 20% PEG 400 before freezing. All other crystals exhibited the highest quality diffraction when frozen directly from the crystal growth condition. All protein crystals were frozen in liquid nitrogen and data were collected at 100 K at beamlines 8.2.1 and 8.2.2 at the Advanced Light Source, Lawrence Berkeley National Laboratory. The wavelengths of data collection for the various crystals were as follows: 1.000030 Å for ancCC, 0.999990 Å for ancR1, 0.999903 Å for ancR2, 0.999983 Å for ancR3, 0.999901 Å for ancR5, 0.999910 Å for ancR7, 0.999985 Å for ancCHI*, and 1.000010 Å for epR4. Data were integrated with iMOSFLM 51 and scaled with SCALA 52 . Arabidopsis thaliana CHI (AtCHI, PDB: 4DOI) was used as a search model for molecular replacement 7 , and phases were solved with PHASER 53 . Models were modified in COOT 54 and refined with PHENIX 55 . For ancCC and ancR1, naringenin was refined to final partial occupancies of 0.79 and 0.59, respectively. The high-resolution data enabled building of alternative conformations for several side chain and backbone atoms in ancCC and ancR1, and the program qfit 56 helped to avoid pitfalls of human bias during this process. For example, S111 is observed with two side chain conformations in "molecule A" of ancCC and ancR1. The highest occupancy conformer of S111 is directed toward naringenin in both structures; however, in ancR1 it is uniquely positioned to hydrogen bond with naringenin. The refined B factors for naringenin are higher for ancCC than for ancR1, perhaps due to less optimal binding contacts between naringenin and active site residues of ancCC relative to ancR1. Statistics for data collection and refinement are in Supplementary Table 10 . Ramachandran outliers for the refined structural models are only observed in epR4, in which Pro54 is an outlier in chains A and B, but not C and D.
electrostatic potential (RESP) procedure 66 (Supplementary Table 12 ). All starting structures for the simulations were prepared using the LEaP module of AMBER. The structures were solvated in a truncated octahedron of TIP3P 67 water molecules, extending to at least 10 Å from the protein atoms. Na + and Cl -ions were added to obtain a charge neutralized system with an ion concentration of 0.15 M.
All systems were initially minimized (1,000 steps steepest descent followed by conjugate gradient minimization) with a 25 kcal mol −1 Å −2 harmonic positional restraint applied to all solute atoms, followed by two more minimization steps with the restraint dropped to 5 kcal mol
The minimized systems were then gradually heated from 100 to 300 K over 40 ps simulation time at constant volume (NVT ensemble), with the temperature equilibrated for a further 60 ps. The density of the system was then equilibrated by performing 300 ps of constant pressure (NPT) simulations with isotropic position scaling, using the Berendsen barostat 68 for pressure control. The 5 kcal mol −1 Å −2 positional restraint was retained for both heating and density equilibration, and this restraint was gradually released over 350 ps of NVT simulations, with the restraint completely removed for a final 50 ps of equilibration time. An additional 50 kcal mol −1 rad 2 harmonic restraint was applied to the C1-C2-C3-C4 torsion angle of the substrate (see Supplementary Table 12 for atom numbering) to keep this torsion angle within the range of − 20° to 90°; this restraint was also removed in the last 50 ps of the initial equilibration. Finally, the initially equilibrated systems were subjected to 100 ns of fully unrestrained production simulations in an NVT ensemble. This protocol was repeated five times for each system to generate five independent trajectories, resulting in 500 ns of simulation time per system, the r.m.s. deviation convergence of which is shown in Supplementary Fig. 20 . The simulation replicas for each system were generated by carrying out five independent simulations starting from the same initial structure but assigning different random set of initial velocities to the system in each replica. A 2 fs time step was used throughout, and all bonds involving hydrogen atoms were constrained using the SHAKE algorithm 69 . The temperature was controlled using Langevin dynamics 70 with a 1 ps −1 collision frequency, and long-range electrostatic interactions were calculated using the Particle Mesh Ewald (PME) method 71 . An 8 Å cutoff was used to describe nonbonded interactions.
Finally, all simulations were analyzed using CPPTRAJ from the AmberTools package, Visual Molecular Dynamic package 72 and MDTraj 1.8.0 library 73 , and the structure graphics were prepared using UCSF Chimera package 74 .
Reporting Summary. Further information on experimental design is available in the Reporting Summary.
Data availability.
Coordinates and structure factors have been deposited in the Protein Data Bank under accession codes 5WKR (ancCC), 5WKS (ancR1), 5WL3 (ancR2), 5WL4 (ancR3), 5WL5 (ancR5), 5WL6 (ancR7), 5WL7 (ancCHI*), and 5WL8 (epR4). All other data generated or analyzed during this study are included in the published article (and/or the associated Supplementary Results) or are available from the corresponding authors upon reasonable request.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
More information including references for each of the software mentioned below (except Excel and Kaleidagraph) can be found in the Online Methods. Briefly, the structural alignment was performed using Expresso. The phylogenetic tree was generated with MrBayes and ancestral inference performed using FastML. Enzyme kinetics data was analyzed using Microsoft Excel (version 14.7.2) and Kaleidagraph (version 4.5.2). X-ray crystallographic data were integrated with iMOSFLM and scaled with SCALA. Phases were solved with PHASER, models modified in COOT and refined with PHENIX. NMR data was processed using NMRpipe, Sparky and Relax. All MD simulations were performed using the AMBER16 simulation package and analyzed using CPPTRAJ from the AmberTools package, Visual Molecular Dynamic package and MDTraj 1.8.0 library.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
No unique materials were used.
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
No antibodies were used. n/a
